Background Deep vein thrombosis with arteriovenous fistulas is rare, with few therapeutic
options available for chronic-phase deep vein thrombosis. Moreover, the effectiveness of …

Venous thromboembolism (VTE) is a chronic illness that affects nearly 10 million people
every year worldwide. Anticoagulant therapy with direct oral anticoagulants is the mainstay …

Background: Pelvic and acetabular fractures are major orthopaedic injuries, which are
known to have high rates of life-threatening venous thromboembolism (VTE) following …

Purpose: This study aimed to develop and validate a specific risk-stratification nomogram
model for the prediction of venous thromboembolism (VTE) in hospitalized patients with lung …

The prediction of post-thrombotic syndrome (PTS) development among patients with deep
venous thrombosis (DVT) is currently based on clinical characteristics alone; reliable …

Venous leg ulcers are the result of elevated ambulatory venous pressure and venous
hypertension. Deep vein thrombosis (DVT) is one of the causes of venous outflow …

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are collectively referred to as
“venous thromboembolic events”(VTE). Despite advances in prophylaxis, diagnosis, and …

Objective Venous thromboembolism is a disease that encompasses both deep vein
thrombosis and pulmonary embolism. Recent investigations have shown that receptor …

Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary
embolism (PE) and is a huge contributor to global disease burden, affecting millions of …

She was treated with rivaroxaban 15 mg twice daily for 21 days, followed by 20 mg once
daily. The DVT remained unexplained by a classical risk factor. She has not had any surgery …